Business Context and Reporting Period
Company: Spero Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 16, 2019
Event: Entry into a Material Definitive Agreement (Second Amendment to Lease Agreement) for corporate headquarters located at 675 Massachusetts Avenue, Cambridge, Massachusetts.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. It specifically details a new direct financial obligation related to office space expansion:
- Expansion Premises: Addition of approximately 7,800 square feet of office space.
- Lease Term Extension: Extended to expire on May 31, 2027 (commencing January 1, 2026).
- Annual Base Rent (Expansion Premises): Approximately $585,000 in the first year, increasing annually to approximately $658,805 in the final year of the Lease Term.
- Option Terms: Two consecutive options to extend the lease for five-year periods, with rent calculated at 100% of the fair market rate determined by the Landlord.
- Additional Costs: Company obligated to pay certain costs, taxes, and operating expenses.
Material Changes Versus Prior Period
The filing does not provide comparative financial data against prior periods. The material change is the modification of the existing lease agreement (originally dated August 24, 2015, and amended January 17, 2018) to include additional square footage and an extended expiration date.
Guidance, Outlook, and Risks
Management Commentary: The filing summarizes the terms of the Second Amendment but does not include forward-looking guidance on clinical trials, product development, or financial performance.
Risks and Contingencies:
- Financial Obligation: Creation of a direct financial obligation for rent and operating expenses.
- Market Rate Risk: Future rent during Option Terms is subject to the Landlord's good faith determination of fair market rates.
Important Facts for Investor Verification
- Verify the total committed lease obligation by reviewing the full text of the Second Amendment (Exhibit 99.1).
- Confirm the impact of the new rent obligation ($585,000 starting) on the company's current cash runway and liquidity position.
- Review the specific conditions required to exercise the two five-year extension options.
- Assess the necessity of the 7,800 square foot expansion relative to current headcount and operational needs.